This guidance sets out the circumstances in which it may be appropriate to offer a course of prophylactic antiviral medicine to patients with a serious underlying medical condition or who are pregnant during the H1N1 (swine flu) pandemic.
Related articles
-
HSJ KnowledgePartnership working and the flu pandemic
The H1N1 pandemic never reached the intensity feared, but the emergency response set in place has strengthened partnership working.
-
NewsSwine flu vaccine bill cost department £239m
The government spent £239m on the swine flu vaccine, official figures reveal.
-
NewsRise in intensive care beds occupied by flu patients
The number of flu cases being treated in critical care beds has increased by 66 per cent in the last week, according to figures released by the Department of Health.
More from News
-
NewsHSJ’s 10 most-read stories of 2023
As 2023 draws to a close, HSJ takes a look at its most-read stories of the year.
-
NewsThe NHS in 2023, told through 13 charts
Throughout 2023, HSJ has strived to make sense of the major challenges and trends for the health service.
-
NewsRevealed: the 10 most influential Black and minority ethnic leaders in English health and care
Four NHS England chiefs, three senior clinical leaders, a trust chief executive, a union boss, and the chair of the NHS Confederation make up the first ever top 10 in HSJ’s annual ranking of the most influential health and care figures from a Black or minority ethnic background. This year’s ...
No comments yet